4basebio PLC (AIM:4BB)
London
· Delayed Price · Currency is GBP · Price in GBX 1,125.00
-5.00 (-0.44%)
Apr 17, 2025, 4:35 PM GMT+1
4basebio Market Cap
4basebio has a market cap or net worth of 144.06 million as of April 17, 2025. Its market cap has increased by 20.97% in one year.
Market Cap
144.06M
Enterprise Value
156.83M
Revenue
596.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1,125.00
Market Cap Chart
Since February 17, 2021, 4basebio's market cap has increased from 41.57M to 144.06M, an increase of 246.53%. That is a compound annual growth rate of 34.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 144.06M | -7.02% |
| Dec 31, 2024 | 154.94M | 84.96% |
| Dec 29, 2023 | 83.77M | -4.21% |
| Dec 30, 2022 | 87.45M | 15.45% |
| Dec 31, 2021 | 75.75M | 82.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.00B |
| GSK plc | 54.20B |
| Haleon | 34.56B |
| Smith & Nephew | 8.61B |
| ConvaTec Group | 5.18B |
| Hikma Pharmaceuticals | 4.16B |
| HUTCHMED (China) | 1.81B |
| Oxford Nanopore Technologies | 1.12B |